Corvinus
Corvinus

Economic aspects of biosimilar competition in Hungary — The treatment of rheumatic disorders

Zrubka, Zsombor (2017) Economic aspects of biosimilar competition in Hungary — The treatment of rheumatic disorders. Society and Economy, 39 (2). pp. 271-290. DOI https://doi.org/10.1556/204.2017.39.2.6

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
875kB

Official URL: https://doi.org/10.1556/204.2017.39.2.6


Abstract

Biologicals are the fastest growing segment of the global pharmaceutical market, reaching 199 billion USD sales per year with 9.8% 10-year compound annual growth rate (CAGR). Being less costly, yet equally efficacious and safe alternatives to originator reference products, biosimilars drive competition, promise budget savings and the opportunity for better patient-access. This paper examines the key factors and players of biosimilar competition in rheumatology in Hungary. Due to the scarcity of data, the total yearly expenditure on biologicals could only be estimated from different data sources. In 2015 the estimated expenditure on biologicals was around 100 billion HUF. In rheumatology indications the expenditure on biologicals was 10 (8.9-11.2) billion HUF, and the average annual net treatment cost was 1.2 (1.06-1.34) million HUF / per patient / year. The magnitude of societal benefits in terms of budget savings and health gains may result from the joint effort of policy makers, funders, physicians and patients. In rheumatology indications, biosimilar utilization could be increased by a policy supporting physician-driven interchange of the reference product to biosimilars. Also, creating a physician incentive system for broader use should be considered in order to realize the full economic advantages of biosimilars and contribute to sustainable healthcare financing in Hungary.

Item Type:Article
Uncontrolled Keywords:biosimilar, rheumatology, Hungary
JEL classification:I11 - Analysis of Health Care Markets
Subjects:Social welfare, insurance, health care
DOI:https://doi.org/10.1556/204.2017.39.2.6
ID Code:3042
Deposited By: Ádám Hoffmann
Deposited On:13 Sep 2017 13:50
Last Modified:13 Sep 2017 13:50

Repository Staff Only: item control page